Novavax, Inc.
Vaccine compositions having improved stability and immunogenicity
Last updated:
Abstract:
Disclosed herein are nanoparticles suitable for use in vaccines. The nanoparticles present antigens from pathogens surrounded to and associated with a detergent core resulting in enhanced stability and good immunogenicity. Dosages, formulations, and methods for preparing the vaccines and nanoparticles are also disclosed.
Status:
Grant
Type:
Utility
Filling date:
6 Sep 2016
Issue date:
1 Oct 2019